Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Teva Pharmaceutical Industries Limited (TEVA)

NYSE

$39,48

$+0,25

(+0,64%)

Pre-Market

Teva Pharmaceutical Industries Limited (TEVA) Live Price Chart

Last updated: ⁦2026-09-16 12:10:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Teva Pharmaceutical Industries Limited (TEVA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $39,48, with a market capitalisation of $45,12B and a P/E ratio of 64,69. Over the past 52 weeks, its price has ranged from $18,21 to $39,56. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$45,12B
Open	$39,17
Day's High	$72,31
Day's Low	$6,07
Previous Close	$39,25
Volume	6,65K
Average Volume	5,43M
P/E Ratio	64,69
52-Week High	$39,56
52-Week Low	$18,21
Dividend Yield	--
Earnings Date	--

Teva Pharmaceutical Industries Limited (TEVA) Pre-Market Stock Price

Teva Pharmaceutical Industries Limited (TEVA) is trading at $39,48 in pre-market trading as of 2026-09-16 11:53:07, up 0,57% ($0,23) from the previous close of $39,25

Pre-market trading shows how investors are pricing TEVA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Teva Pharmaceutical Industries Limited (TEVA) 7-Day Stock Price Change

Over the past seven days, Teva Pharmaceutical Industries Limited (TEVA) moved from $36,36 to $39,48, representing a gain of 8,57% ($3,12).

The stock traded between $35,42 and $39,56 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 4,92 million shares, up versus the previous seven-day period, indicating higher trading activity.

TEVA 52-Week Price Position

Position in Range: 99,6%

52W Low$18,21

52W High$39,56

TEVA is currently trading at $39,48, placing it 99,6% of the way from its 52-week low of $18,21 to its 52-week high of $39,56. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Teva Pharmaceutical Industries Limited (TEVA)?

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Limited Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	32842
Exchange	NYSE
Company Website	https://www.tevapharm.com

How to Buy Teva Pharmaceutical Industries Limited (TEVA) Stock on MEXC

Eligible investors can buy real shares of Teva Pharmaceutical Industries Limited (TEVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TEVA and Place Your Order

Open the RealStocks trading page and search for TEVA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Teva Pharmaceutical Industries Limited (TEVA) stock price today?

Teva Pharmaceutical Industries Limited (TEVA) is currently trading at $ 39,48, up 0,57% ($0,23) from the previous close of $ 39,25. Intraday prices update in real time during regular trading hours.

2.Is TEVA stock going up or down today?

As of 2026-09-16 11:53:07, TEVA is trading at $ 39,48, up 0,57% ($0,23) from its previous close of $ 39,25. The stock has traded between $ 6,07 and $ 72,31 during today’s regular session. Past price movements do not guarantee future results.

3.What is TEVA pre-market price?

As of 2026-09-16 11:53:07, TEVA is trading at $ 39,48 in pre-market trading, up 0,57% ($0,23) from the previous close of $ 39,25. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TEVA after-hours price?

As of 2026-09-16 11:53:07, TEVA is trading at -- in after-hours trading, -- from the regular-session close of $ 39,25. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TEVA stock trading now?

TEVA trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TEVA sit relative to its 52-week high and low?

Over the past 52 weeks, TEVA has traded between a low of $ 18,21 and a high of $ 39,56. At $ 39,48, the stock is positioned 99,6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Teva Pharmaceutical Industries Limited in?

Teva Pharmaceutical Industries Limited (TEVA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Teva Pharmaceutical Industries Limited's market capitalisation and where is it listed?

Teva Pharmaceutical Industries Limited is listed on the NYSE exchange with a market capitalisation of $ 45,12B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TEVA valued in terms of P/E ratio and EPS?

TEVA trades at a P/E ratio of 64,69, based on trailing-twelve-month EPS of $ 0,61. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Teva Pharmaceutical Industries Limited pay a dividend?

Teva Pharmaceutical Industries Limited pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.